The CME derivatives monopoly lawsuit filed against the Commodity Futures Trading Commission (CFTC) on 18 June 2026 has drawn an unusually blunt counterattack from the crypto side of the derivatives market. Jake Chervinsky, chief executive of the Hyperliquid Policy Center, called the move a ‘shocking miscalculation’ and ‘an unforced error,’ arguing that CME Group had exposed itself as ‘a petty incumbent monopolist afraid of competition.’
The lawsuit, filed in the United States District Court for the District of Columbia according to a Lowenstein Sandler client alert, specifically challenges the CFTC’s 29 May 2026 order approving KalshiEX’s bitcoin perpetual futures contract and an accompanying policy statement on listing perpetual contracts. The CFTC’s May action also issued guidance on 24/7 trading and clearing operations and released an interpretive letter covering Coinbase Financial Markets’ access to perpetuals listed on its foreign affiliate, Deribit.
The timing cuts two ways. Bloomberg reported the suit landed one day after longtime CME chief Terry Duffy announced he would step back early next year. CME’s complaint alleges CFTC Chairman Michael Selig overrode congressional direction and ‘circumvented the regulatory regime’ required for approving perpetual contracts as futures products, a classification that carries more favourable tax treatment than swaps.
What the CME Derivatives Monopoly Lawsuit Reveals About Market Structure
The Hyperliquid Policy Center’s 18 June post on X cited Better Markets data estimating CME controls roughly 92% of U.S. exchange-traded derivatives volume. The group’s framing was direct: ‘CME runs about 92% of U.S. exchange-traded derivatives. When one venue holds that much volume, everyone else carries the cost. Less choice, higher prices.’
That concentration figure gives Chervinsky’s incumbency argument its teeth. The Hyperliquid Policy Center also noted that U.S. traders spent years accessing perpetual futures exclusively through offshore venues, with no regulated domestic equivalent available. Perpetual futures, the group argued, represent the first genuinely new derivatives product to reach regulated U.S. markets in more than a decade.
The regulated products that triggered the dispute have already generated more than $1 billion in trading volume since launch. CME, by contrast, reported a May 2026 average daily volume of 33.2 million contracts, a monthly record up 15% year over year, per a CME Group press release. For an exchange posting those numbers, the decision to sue a regulator over a nascent product category reads, to Chervinsky at least, as disproportionate.
Chervinsky posted his comments on X on 19 June, the day after the CME derivatives monopoly lawsuit became public. He quoted Selig’s own words back at CME: the CFTC chairman had said ‘vested interests always fear the future,’ and the Hyperliquid Policy Center argued the remark applied here.
A Joint Regulatory Review Complicates CME’s Argument
CME’s legal theory rests on classification. Outgoing chief executive Terrence Duffy told CNBC this week that perpetual contracts fit within the swap category established by Dodd-Frank, and the company’s court filing contends the CFTC approved a new product type without following the rulemaking process Congress prescribed.
The problem for that argument is that the regulators themselves are no longer certain where the lines fall. The CFTC and the Securities and Exchange Commission have jointly opened a public consultation on how swaps, security-based swaps, mixed swaps, and related products should be classified under Title VII of Dodd-Frank, according to the SEC’s joint press release. The comment window runs for 60 days after Federal Register publication.
Selig framed the review as ‘an opportunity to address longstanding ambiguities within Title VII of Dodd-Frank that have stifled fair competition and responsible innovation.’ SEC Chairman Paul Atkins added that additional clarification is overdue. Both regulators are essentially conceding that the definitional framework CME is invoking is unsettled, which weakens the premise that the CFTC acted outside established rules when it approved perpetual contracts as futures.
CME’s lawsuit asks the court to resolve what two regulators have now put out for public comment. If the joint consultation produces a revised classification framework before the case is decided, the legal ground CME is standing on shifts underneath it.
